tiprankstipranks
PharmGen Science, Inc. (KR:004720)
:004720
South Korea Market
004720
PharmGen Science, Inc.
RESEARCH TOOLSreports

PharmGen Science, Inc. (004720) Financial Statements

― Followers

PharmGen Science, Inc. Financial Overview

PharmGen Science, Inc.'s market cap is currently ₩68.40B. The company's EPS TTM is ₩-6137; its P/E ratio is -0.49; PharmGen Science, Inc. is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 173.07B₩ 171.29B₩ 166.78B₩ 150.93B₩ 109.87B
Gross Profit₩ 109.13B₩ 108.03B₩ 96.20B₩ 81.30B₩ 60.80B
Operating Income₩ 5.99B₩ 10.64B₩ 9.13B₩ 9.32B₩ -4.94B
EBITDA₩ 10.53B₩ 10.79B₩ 13.37B₩ 10.78B₩ -254.11M
Net Income₩ -116.64B₩ 2.79B₩ 5.73B₩ 70.06B₩ 32.47B
Balance Sheet
Cash & Short-Term Investments₩ 22.41B₩ 38.45B₩ 37.44B₩ 19.89B₩ 34.19B
Total Assets₩ 195.41B₩ 363.45B₩ 335.92B₩ 317.39B₩ 220.32B
Total Debt₩ 6.00B₩ 38.99B₩ 37.96B₩ 39.49B₩ 48.01B
Net Debt₩ -15.88B₩ 1.07B₩ 1.06B₩ 20.14B₩ 14.35B
Total Liabilities₩ 49.11B₩ 114.02B₩ 107.71B₩ 110.28B₩ 93.39B
Stockholders' Equity₩ 146.30B₩ 249.44B₩ 228.22B₩ 207.12B₩ 126.94B
Cash Flow
Free Cash Flow₩ 3.86B₩ -399.26M₩ 2.15B₩ -13.24B₩ -26.23B
Operating Cash Flow₩ 5.32B₩ 2.38B₩ 5.44B₩ -1.29B₩ 7.78B
Investing Cash Flow₩ -2.42B₩ -889.45M₩ 3.26B₩ -15.28B₩ -30.39B
Financing Cash Flow₩ -18.93B₩ -483.95M₩ 8.85B₩ 2.27B₩ 30.34B
Currency in KRW

PharmGen Science, Inc. Earnings and Revenue History

Income Statement >

PharmGen Science, Inc. Debt to Assets

Balance Sheet >

PharmGen Science, Inc. Cash Flow

Cash Flow >

PharmGen Science, Inc. Forecast EPS vs Actual EPS

Earnings >